Transient striatal GLT-1 blockade increases EAAC1 expression, glutamate reuptake, and decreases tyrosine hydroxylase phosphorylation at ser 19

Experimental Neurology

Volumn 234, Issue 2, 2012, Pages 428-436

  Salvatore, Michael F ^a   Davis, Richard W ^a   Arnold, Jennifer C ^a   Chotibut, Tanya ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

EAAC1 EAAT3; Excitotoxicity; GLAST EAAT1; GLT 1 EAAT2; Glutamate; Glutathione; Nigrostriatal; Parkinson's disease; Phosphorylation; Striatum; Tyrosine hydroxylase

Indexed keywords

CALCIUM ION; DIHYDROKAINIC ACID; EXCITATORY AMINO ACID TRANSPORTER; EXCITATORY AMINO ACID TRANSPORTER 1; GLUTAMATE RECEPTOR ANTAGONIST; TYROSINE 3 MONOOXYGENASE; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CALCIUM TRANSPORT; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME PHOSPHORYLATION; EX VIVO STUDY; EXCITOTOXICITY; IN VIVO STUDY; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TRANSPORT; RAT; SYNAPTOSOME;

ANIMALS; ASTROCYTES; CALCIUM; CORPUS STRIATUM; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMIC ACID; KAINIC ACID; MALE; NEURONS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES; TYROSINE 3-MONOOXYGENASE;

EID: 84858150213     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.01.012     Document Type: Article

References (73)

1. Ambrosi G., Armentero M.-T., Levandis G., Bramanti P., Nappi G., Blandini F. Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease. Brain Res. Bull. 2010, 82:29-38.
2. Aoyama K., Suh S.W., Hamby A.M., Liu J., Chan W.Y., Chen Y., Swanson R.A. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat. Neurosci. 2006, 9:119-126.
3. Aoyama K., Matsumura N., Watabe M., Nakaki T. Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction. Eur. J. Neurosci. 2008, 27:20-30.
4. Aoyama K., Watabe M., Nakaki T. Modulation of neuronal glutathione synthesis by EAAC1 and its interacting protein GTRAP3-18. Amino Acids 2012, 42:163-169.
5. Armentero M.-T., Fancellu R., Nappi G., Bramanti P., Blandini F. Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease. Neurobiol. Dis. 2006, 22:1-9.
6. Azarias G., Perreten H., Lengacher S., Poburko D., Demaurex N., Magistretti P.J., Chatton J.-Y. Glutamate transport decreases mitocondrial pH and modulates oxidative metabolism in astrocytes. J. Neurosci. 2011, 31:3550-3559.
7. Bechtholt-Gompf A.J., Walther H.V., Adams M.A., Carlezon W.A., Ongur D., Cohen B.M. Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory. Neuropsychopharmacology 2010, 35:2049-2059.
8. Behrens P.F., Franz P., Woodman B., Lindenberg K.S., Landwehrmeyer G.B. Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 2002, 125:1908-1922.
9. Berman A.E., Chan W.Y., Brennan A.M., Reyes R.C., Adler B.L., Suh S.W., Kauppinen T.M., Edling Y., Swanson R.A. N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse. Ann. Neurol. 2011, 69:509-520.
10. Chung E.K., Chen L.W., Chan Y.S., Yung K.K. Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats. J. Comp. Neurol. 2008, 511:421-437.
11. Dabir D.V., Robinson M.B., Swanson E., Zhang B., Trojanowski J.Q., Lee V.M.-Y., Forman M.S. Impaired glutamate transport in a mouse model of tau pathology in astrocytes. J. Neurosci. 2006, 26:644-654.
12. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
13. Danbolt N.C., Holmseth S., Dehnes Y., Huang Y.H., Follin-Arbelet V., Grutle N.J., Zhou Y., Plachez C., Furness D.N., Bergles D.E., Lehre K.P. Quantification and localization of the EAAC1 glutamate transporter in brain. Soc. Neurosci. 2011, Abstracts, 342.12.
14. Del Rio P., Montiel T., Massieu L. Contribution of NMDA and non-NMDA receptors to in vivo glutamate-induced calpain activation in the rat striatum. Relation to neuronal damage. Neurochem. Res. 2008, 33:1475-1483.
15. Dervan A.G., Meshul C.K., Beales M., McBean G.J., Moore C., Totterdell S., Snyder A.K., Meredith G.E. Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease. Exp. Neurol. 2004, 190:145-156.
16. DeSilva T.M., Kabakov A.Y., Goldhoff P.E., Volpe J.J., Rosenberg P.A. Regulation of glutamate transport in developing rat oligodendrocytes. J. Neurosci. 2009, 29:7898-7908.
17. Dolinska M., Albrecht J. Glutamate uptake is inhibited by L-arginine in mitochondria isolated from rat cerebrum. Neuroreport 1997, 8:2365-2368.
18. Donzanti B.A., Hite J.F., Yamamoto B.K. Extracellular glutamate levels increase with age in the lateral striatum: potential involvement of presynaptic D-2 receptors. Synapse 1993, 13:376-382.
19. Duan S., Anderson C.M., Stein B.A., Swanson R.A. Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J. Neurosci. 1999, 19:10193-10200.
20. Fumagalli E., Funicello M., Rauen T., Gobbi M., Mennini T. Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. Eur. J. Pharmacol. 2008, 587:171-176.
21. Garrido M., Tereshchenko Y., Zhevtsova Z., Taschenberger G., Bahr M., Kugler S. Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons. Acta Neuropathol. 2011, 121:475-485.
22. Geddes J.W., Saatman K.E. Targeting individual calpain isoforms for neuroprotection. Exp. Neurol. 2010, 226:6-7.
23. Genda E.N., Jackson J.G., Sheldon A.L., Locke S.F., Greco T.M., O'Donnell J.C., Spruce L.A., Xiao R., Guo W., Putt M., Seeholzer S., Ischiropoulos H., Robinson M.B. Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria. J. Neurosci. 2011, 31:18275-18288.
24. Grant R.J., Sellings L.H., Crocker S.J., Melloni E., Park D.S., Clarke P.B. Effects of calpain inhibition on dopaminergic markers and motor function following intrastriatal 6-hydroxydopamine administration in rats. Neuroscience 2009, 158:558-569.
25. Greenamyre J.T. Glutamatergic influences on the basal ganglia. Clin. Neuropharmacol. 2001, 24:65-70.
26. Haycock J.W., Haycock D.A. Tyrosine hydroxylase in rat brain dopaminergic nerve terminals: multiple-site phosphorylation in vivo and in synaptosomes. J. Biol. Chem. 1991, 266:5650-5657.
27. Henn F.A., Anderson D.J., Rustad D.G. Glial contamination of synaptosomal fractions. Brain Res. 1976, 101:341-344.
28. Himi T., Ikeda M., Yasuhara T., Nishida M., Morita I. Role of neuronal glutamate transporter in the cysteine uptake and intracellular glutathione levels in cultured cortical neurons. J. Neural Transm. 2003, 110:1337-1348.
29. Jensen A.A., Erichsen M.N., Nielsen C.W., Stensbol T.B., Kehler J., Bunch L. Discovery of the first selective inhibitor of excitatory amino acid transporter subtype 1. J. Med. Chem. 2009, 52:912-915.
30. Karlsson R.-M., Tanaka K., Heilig M., Holmes A. Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist. Biol. Psychiatry 2008, 64:810-814.
31. Lau A., Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010, 460:525-542.
32. Lee Y., Gaskins D., Anand A., Shekar A. Glia mechanisms in mood regulation: a novel model of mood disorders. Psychopharmacology 2007, 191:55-65.
33. Lindefors N., Ungerstedt U. Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons. Neurosci. Lett. 1990, 115:248-252.
34. 40 via activation of glutamate NMDA receptors in rat striatum. J. Neurochem. 2000, 74:2470-2477.
35. Masilamoni G.J., Bogenpohl J.W., Alagille D., Delevich K., Tamagnan G., Votaw J.R., Wichmann T., Smith Y. Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys. Brain 2011, 134:2057-2073.
36. Massie A., Goursaud S., Schallier A., Vermoesen K., Meshul C.K., Hermans E., Michotte Y. Time-dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats. Neurochem. Int. 2010, 57:572-578.
37. Massieu L., Tapia R. Glutamate uptake impairment and neuronal damage in young and aged rats in vivo. J. Neurochem. 1997, 69:1151-1160.
38. Massieu L., Morales-Villagran A., Tapia R. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study. J. Neurochem. 1995, 64:2272.
39. Meredith G.E., Totterdell S., Beales M., Meshul C.K. Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease. Exp. Neurol. 2009, 219:334-340.
40. Meshul C.K., Emre N., Nakamura C.M., Allen C., Donohue M.K., Buckman J.F. Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. Neuroscience 1999, 88:1-16.
41. Meshul C.K., Cogen J.P., Cheng H.W., Moore C., Krentz L., McNeill T.H. Alterations in rat striatal glutamate synapses following a lesion of the cortico- and/or nigrostriatal pathway. Exp. Neurol. 2000, 165:191-206.
42. Miller H.P., Levey A.I., Rothstein J.D., Tzingounis A.V., Conn P.J. Alterations in glutamate transporter protein levels in kindling-induced epilepsy. J. Neurochem. 1997, 68:1564-1570.
43. Nickell J., Pomerleau F., Allen J., Gerhardt G.A. Age-related changes in the dynamics of potassium-evoked L-glutamate release in the striatum of Fisher 344 rats. J. Neural Transm. 2005, 112:87-96.
44. Nickell J., Salvatore M.F., Pomerleau F., Apparsundaram S., Gerhardt G.A. Reduced plasma membrane surface expression of GLAST mediates decreased glutamate regulation in the aged striatum. Neurobiol. Aging 2007, 28:1737-1748.
45. Nieoullon A., Canolle B., Masmejan F., Guillet B., Pisano P., Lortet S. The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse?. J. Neurochem. 2006, 98:1007-1018.
46. Pintor A., Galluzzo M., Grieco R., Pezzola A., Reggio R., Popoli P. Adenosine A 2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors. J. Neurochem. 2004, 89:152-156.
47. Plaitakis A., Shashidharan P. Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implication for the pathogenesis of Parkinson's disease. J. Neurol. 2000, 247:II/25-II/35.
48. Robinson M.B. The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype. Neurochem. Int. 1998, 33:479-491.
49. 3H]glutamate transport processes in rat brain. Brain Res. 1991, 544:192-202.
50. Robinson S., Freeman P., Moore C., Touchon J.C., Krentz L., Meshul C.K. Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function. Exp. Neurol. 2003, 180:73-86.
51. Rosenberg P.A., Aizenman E. Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci. Lett. 1989, 103:162-168.
52. Ross J.R., Ramakrishnan H., Porter B.E., Robinson M.B. Group I mGluR-regulated translation of the neuronal glutamate transporter, excitatory amino acid carrier 1. J. Neurochem. 2011, 117:812-823.
53. Ross J.R., Porter B.E., Buckley P.T., Eberwine J.H., Robinson M.B. mRNA for the EAAC1 subtype of glutamate transporter is present in neuronal dendrites in vitro and dramatically increases in vivo after a seizure. Neurochem. Int. 2011, 58:366-375.
54. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kunci R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
55. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Hoberg M.D., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z., Gupta P., Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433:73-77.
56. Salvatore M.F., Waymire J.C., Haycock J.W. Depolarization-stimulated catecholamine biosynthesis: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ. J. Neurochem. 2001, 79:349-360.
57. Salvatore M.F., Apparsundaram S., Gerhardt G.A. Decreased plasma membrane expression of striatal dopamine transporter in aging. Neurobiol. Aging 2003, 24:1147-1154.
58. Salvatore M.F., Pruett B.S., Spann S.L., Dempsey C. Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generation. PLoS One 2009, 5:e8466.
59. Sanchez-Pernaute R., Wang J.-Q., Kuruppu D., Cao L., Tueckmantel W., Kozikowski A., Isacson O., Brownell A.-L. Enhanced binding of metabotropic glutamate receptor type 5 (mGluR5) PET tracers in the brain of parkinsonian primates. NeuroImage 2010, 42:248-251.
60. (2+) signaling in neuronal mitochondria. J. Neurosci. Res. 2007, 85:3359-3366.
61. Schallier A., Smolders I., Van Dam D., Loyens E., De Deyn P.P., Michotte A., Michotte Y., Massie A. Region- and age-specific changes in glutamate transport in the AßPP23 mouse model for Alzheimer's disease. J. Alzheimer's Dis. 2011, 24:287-300.
62. Selkirk J.V., Nottebaum L.M., Vana A.M., Verge G.M., MacKay K.B., Stiefel T.H., Naeve G.S., Pomeroy J.E., Petroski R.E., Moyer J., Dunlop J., Foster A.C. Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus. Eur. J. Neurosci. 2005, 21:3217-3228.
63. Sheldon A.L., Robinson M.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 2007, 51:333-355.
64. Suchak S.K., Baloyianni N.V., Perkinton M.S., Williams R.J., Meldrum B.S., Rattray M. The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings. J. Neurochem. 2003, 84:522-532.
65. Ulas J., Weihmuller F.B., Brunner L.C., Joyce J.N., Marshall J.F., Cotman C.W. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study. J. Neurosci. 1994, 14:6317-6324.
66. Velasco I., Tapia R., Massieu L. Inhibition of glutamate uptake induces progressive accumulation of extracellular glutamate and neuronal damage in rat cortical cultures. J. Neurosci. Res. 1996, 44:551-561.
67. Vernon A.C., Zbarsky V., Datla K.P., Croucher M.J., Dexter D.T. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo. J. Neurochem. 2007, 103:1075-1091.
68. Wang G.J., Chung H.J., Schnuer J., Lea E., Robinson M.B., Potthoff W.K., Aizenman E., Rosenberg P.A. Dihydrokainate-sensitive neuronal glutamate transport is required for protection of rat cortical neurons in culture against synaptically released glutamate. Eur. J. Neurosci. 1998, 10:2523-2531.
69. Wassum K.M., Tolosa V.M., Wang J., Walker E., Monbouquette H.G., Maidment N.T. Silicon wafer-based platinum microelectrode array biosensor for near real-time measurement of glutamate in vivo. Sens. Basel Sens. 2008, 8:5023-5036.
70. Weihmuller F.B., Ulas J., Nguyen L., Cotman C.W., Marshall J.F. Elevated NMDA receptors in parkinsonian striatum. Neuroreport 1992, 3:977-980.
71. Yamamoto B.K., Davy S. Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J. Neurochem. 1992, 58:1736-1742.
72. Zerangue N., Kavanaugh M.P. Interaction of L-cysteine with a human excitatory amino acid transporter. J. Physiol. 1996, 493:419-423.
73. Ziemińska E., Hilgier W., Waagepetersen H.S., Hertz L., Sonnewald U., Schousboe A., Albrecht J. Analysis of glutamine accumulation in rat brain mitochondria in the presence of a glutamine uptake inhibitor, histidine, reveals glutamine pools with a distinct access to deamidation. Neurochem. Res. 2004, 29:2121-2123.